$GBLX
GB SCIENCES INC

2022 Q1 Form 10-K Financial Statement

#000143774922016285 Filed on June 30, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $451.0K $1.869M $324.1K
YoY Change 39.14% -6.64% -72.67%
% of Gross Profit
Research & Development $821.3K
YoY Change 133.15%
% of Gross Profit
Depreciation & Amortization $17.07K $25.78K $17.25K
YoY Change -1.04% -25.62% -51.38%
% of Gross Profit
Operating Expenses $451.0K $821.3K $324.1K
YoY Change 39.13% 133.15% -72.67%
Operating Profit -$451.0K -$1.869M -$324.1K
YoY Change 39.13% -6.64% -72.67%
Interest Expense -$154.8K $474.8K -$35.47K
YoY Change 336.4% -63.07% -78.67%
% of Operating Profit
Other Income/Expense, Net $15.64K $1.722M $35.85K
YoY Change -56.37% -229.37% -113.32%
Pretax Income -$3.608M -$146.5K -$323.8K
YoY Change 1014.56% -95.6% -91.07%
Income Tax $0.00 $0.00 -$234.6K
% Of Pretax Income
Net Earnings -$3.668M -$530.9K -$478.9K
YoY Change 665.97% -85.75% -94.45%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$11.47K -$1.671K -$1.594K
COMMON SHARES
Basic Shares Outstanding 317.4M 317.6M 293.5M
Diluted Shares Outstanding 343.5M

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.9K $233.9K $793.0K
YoY Change -70.51% -70.51% 422.53%
Cash & Equivalents $233.9K $233.9K $793.0K
Short-Term Investments
Other Short-Term Assets $93.93K $93.93K $2.751M
YoY Change -96.59% -96.59% 4417.67%
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $327.8K $327.8K $3.544M
YoY Change -90.75% -90.75% -49.38%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $25.02K
YoY Change -100.0% -100.0% -33.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $5.530M
YoY Change -100.0% -100.0% 5944.17%
Total Long-Term Assets $2.222M $2.222M $7.262M
YoY Change -69.4% -69.4% -1.22%
TOTAL ASSETS
Total Short-Term Assets $327.8K $327.8K $3.544M
Total Long-Term Assets $2.222M $2.222M $7.262M
Total Assets $2.550M $2.550M $10.81M
YoY Change -76.4% -76.4% -24.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.657M $1.657M $1.412M
YoY Change 17.31% 17.31% -26.17%
Accrued Expenses $9.627K $394.4K $957.9K
YoY Change -99.0% -74.33% 17.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $987.6K $987.6K $3.595M
YoY Change -72.53% -72.53% -36.95%
Total Short-Term Liabilities $3.935M $3.935M $8.598M
YoY Change -54.23% -54.23% -21.01%
LONG-TERM LIABILITIES
Long-Term Debt $397.3K $397.3K $292.4K
YoY Change 35.87% 35.87% -91.72%
Other Long-Term Liabilities $0.00 $0.00 $3.389M
YoY Change -100.0% -100.0% 14949.38%
Total Long-Term Liabilities $397.3K $397.3K $3.682M
YoY Change -89.21% -89.21% 3.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.935M $3.935M $8.598M
Total Long-Term Liabilities $397.3K $397.3K $3.682M
Total Liabilities $4.333M $4.333M $12.28M
YoY Change -64.72% -64.72% -14.97%
SHAREHOLDERS EQUITY
Retained Earnings -$104.6M -$103.9M
YoY Change 0.67% 6.67%
Common Stock $32.50K $31.53K
YoY Change 3.08% 14.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.783M -$1.783M -$1.474M
YoY Change
Total Liabilities & Shareholders Equity $2.550M $2.550M $10.81M
YoY Change -76.4% -76.4% -24.71%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income -$3.668M -$530.9K -$478.9K
YoY Change 665.97% -85.75% -94.45%
Depreciation, Depletion And Amortization $17.07K $25.78K $17.25K
YoY Change -1.04% -25.62% -51.38%
Cash From Operating Activities -$665.2K -$1.866M -$932.0K
YoY Change -28.63% -14.6% 302.75%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$200.0K $33.32K
YoY Change -400.12% -31.67% -308.25%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.650M $27.57K
YoY Change -100.0% -66.65% 72.31%
Cash From Investing Activities -$100.0K $1.450M $60.90K
YoY Change -264.2% -68.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -505.2K -$495.9K 1.095M
YoY Change -146.12% -66.41% 216.7%
NET CHANGE
Cash From Operating Activities -665.2K -$1.866M -932.0K
Cash From Investing Activities -100.0K $1.450M 60.90K
Cash From Financing Activities -505.2K -$495.9K 1.095M
Net Change In Cash -1.270M -$911.7K 224.3K
YoY Change -666.45% -191.74% 95.93%
FREE CASH FLOW
Cash From Operating Activities -$665.2K -$1.866M -$932.0K
Capital Expenditures -$100.0K -$200.0K $33.32K
Free Cash Flow -$565.2K -$1.666M -$965.4K
YoY Change -41.45% -11.96% 348.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
325037557
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
325037557
CY2022 dei Auditor Firm
AuditorFirmId
5036
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104201 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43096 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1765 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
296504 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
99489 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
154590 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
315340411
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315340411
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2021 gblx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
35798809
CY2021 gblx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
6390125
CY2022 gblx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
9697146
CY2022 gblx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
3116550
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233893 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1782872 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
793040 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
93933 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
256251 USD
CY2022Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2494564 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1473928 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2549900 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10806054 USD
CY2022 us-gaap Revenues
Revenues
0 USD
CY2021 us-gaap Revenues
Revenues
0 USD
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
-0 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
-0 USD
CY2022 us-gaap Gross Profit
GrossProfit
0 USD
CY2021 us-gaap Gross Profit
GrossProfit
0 USD
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1868734 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2001617 USD
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1868734 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
327826 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
3543855 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25022 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2222074 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1706762 USD
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 USD
CY2021Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
5530415 USD
CY2022Q1 us-gaap Assets
Assets
2549900 USD
CY2021Q1 us-gaap Assets
Assets
10806054 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1657008 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1412459 USD
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
384769 USD
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
493741 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9627 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
957946 USD
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
987565 USD
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3594804 USD
CY2022Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
0 USD
CY2021Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
84913 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
896495 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
761509 USD
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1293076 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3935464 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8598448 USD
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
397308 USD
CY2021Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
292410 USD
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3389124 USD
CY2022Q1 us-gaap Liabilities
Liabilities
4332772 USD
CY2021Q1 us-gaap Liabilities
Liabilities
12279982 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
32504 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
31534 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102764746 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102380770 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104580122 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103886232 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2001617 USD
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
22405 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
467872 USD
CY2022 gblx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
0 USD
CY2021 gblx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
422414 USD
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 USD
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2022 us-gaap Interest Expense
InterestExpense
474768 USD
CY2021 us-gaap Interest Expense
InterestExpense
1285460 USD
CY2022 gblx Gain Loss On Amendment To Line Of Credit
GainLossOnAmendmentToLineOfCredit
0 USD
CY2021 gblx Gain Loss On Amendment To Line Of Credit
GainLossOnAmendmentToLineOfCredit
-650000 USD
CY2022 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-3025000 USD
CY2021 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
0 USD
CY2022 gblx Debt Default Penalty
DebtDefaultPenalty
-0 USD
CY2021 gblx Debt Default Penalty
DebtDefaultPenalty
286059 USD
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15639 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1722206 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1331233 USD
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146528 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3332850 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-146528 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3332850 USD
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-384345 USD
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-392177 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-530873 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3725027 USD
CY2022 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-146528 USD
CY2021 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-3332850 USD
CY2022 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-384345 USD
CY2021 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-392177 USD
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-530873 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3725027 USD
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
317621942
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285190729
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-88494 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
160000 USD
CY2021 gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
968023 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
436349 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
543886 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
231335 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3725027 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1473928 USD
CY2022 gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
56394 USD
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60667 USD
CY2022 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
28800 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-530873 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1782872 USD
CY2022 us-gaap Profit Loss
ProfitLoss
-530873 USD
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-87772 USD
CY2021 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-118644 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1866154 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2185220 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-3725027 USD
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-384345 USD
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-392177 USD
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-146528 USD
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3332850 USD
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
70488 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
47353 USD
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
60667 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
436349 USD
CY2022 gblx Issuance Of Warrants To Brokers
IssuanceOfWarrantsToBrokers
0 USD
CY2021 gblx Issuance Of Warrants To Brokers
IssuanceOfWarrantsToBrokers
231335 USD
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
356340 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
776122 USD
CY2022 gblx Default Penatly On Convertible Note Payable
DefaultPenatlyOnConvertibleNotePayable
0 USD
CY2021 gblx Default Penatly On Convertible Note Payable
DefaultPenatlyOnConvertibleNotePayable
286059 USD
CY2022 gblx Gain Loss On Amendment To Line Of Credit
GainLossOnAmendmentToLineOfCredit
-0 USD
CY2021 gblx Gain Loss On Amendment To Line Of Credit
GainLossOnAmendmentToLineOfCredit
-650000 USD
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
22405 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
467872 USD
CY2022 gblx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
-0 USD
CY2021 gblx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
422414 USD
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15639 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
CY2022 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-3025000 USD
CY2021 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-0 USD
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 USD
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-0 USD
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-162318 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
237475 USD
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
821253 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-248115 USD
CY2022 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
-948319 USD
CY2021 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
166828 USD
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
118286 USD
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
549703 USD
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-84913 USD
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-501599 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1778382 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2066576 USD
CY2022 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
1648772 USD
CY2021 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0 USD
CY2022 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
0 USD
CY2021 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
5051923 USD
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
200000 USD
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
292675 USD
CY2022 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1448772 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4759248 USD
CY2022 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1567 USD
CY2021 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-103729 USD
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1450339 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4655519 USD
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138728 USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1075396 USD
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
725000 USD
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
375000 USD
CY2022 gblx Repayments Of Principal Notes Payable And Operating Lease Obligation
RepaymentsOfPrincipalNotesPayableAndOperatingLeaseObligation
575000 USD
CY2021 gblx Repayments Of Principal Notes Payable And Operating Lease Obligation
RepaymentsOfPrincipalNotesPayableAndOperatingLeaseObligation
3156014 USD
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
151923 USD
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6266 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
107373 USD
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
74750 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-392538 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1314664 USD
CY2022 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-103387 USD
CY2021 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-161768 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-495925 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1476432 USD
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-911740 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
993867 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1145633 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
151766 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233893 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1145633 USD
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
-0 USD
CY2021Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
352593 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233893 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
793040 USD
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
241014 USD
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2022 gblx Notes Receivable Issued
NotesReceivableIssued
3025000 USD
CY2021 gblx Notes Receivable Issued
NotesReceivableIssued
0 USD
CY2022 us-gaap Notes Reduction
NotesReduction
2612854 USD
CY2021 us-gaap Notes Reduction
NotesReduction
0 USD
CY2022 gblx Accrued Management Fees Payables Reduction
AccruedManagementFeesPayablesReduction
850000 USD
CY2021 gblx Accrued Management Fees Payables Reduction
AccruedManagementFeesPayablesReduction
0 USD
CY2022 gblx Accrued Liabilites Forgiven
AccruedLiabilitesForgiven
0 USD
CY2021 gblx Accrued Liabilites Forgiven
AccruedLiabilitesForgiven
172500 USD
CY2022 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
349015 USD
CY2021 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
532785 USD
CY2022 gblx Accrued Interest Capitalized In Convertible Note Principal
AccruedInterestCapitalizedInConvertibleNotePrincipal
0 USD
CY2021 gblx Accrued Interest Capitalized In Convertible Note Principal
AccruedInterestCapitalizedInConvertibleNotePrincipal
223094 USD
CY2022 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
347617 USD
CY2021 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
319939 USD
CY2022 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
28800 USD
CY2021 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
168000 USD
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
160000 USD
CY2022 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
163017 USD
CY2021 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
2774000 USD
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104580122 USD
CY2022Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
-3607638 USD
CY2021Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
-5054593 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1866154 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2185220 USD
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"><i><b>Use of Estimates</b></i></p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, collectibility of notes receivable, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <em style="font: inherit;">not</em> readily apparent from other sources. The actual results the Company experiences <em style="font: inherit;"> may </em>differ materially and adversely from these estimates.</p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"> </p>
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"><i><b>Reclassifications</b></i></p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Certain reclassifications have been made to the comparative period amounts in order to conform to the current period presentation. In particular, income taxes payable were reclassified from current liabilities from discontinued operations to income taxes payable from discontinued operations, to reflect that this liability, while related to discontinued operations, remains an obligation of GB Sciences, Inc. and was <em style="font: inherit;">not</em> deconsolidated upon the sale of the Nevada Subsidiaries on <em style="font: inherit;"> December 31, 2021 </em>(Note <em style="font: inherit;">13</em>). The reclassifications had <em style="font: inherit;">no</em> effect on the reported financial position, results of operations or cash flows of the Company.</p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
CY2022Q1 gblx Indefinitelived Intangible Assets Pending Number
IndefinitelivedIntangibleAssetsPendingNumber
18 pure
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821321 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
352274 USD
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
118594624
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164049941
CY2021Q1 us-gaap Inventory Net
InventoryNet
0 USD
CY2022 us-gaap Depreciation
Depreciation
25775 USD
CY2021 us-gaap Depreciation
Depreciation
34654 USD
CY2022 gblx Depreciation Capitalized To Inventory
DepreciationCapitalizedToInventory
349015 USD
CY2021 gblx Depreciation Capitalized To Inventory
DepreciationCapitalizedToInventory
532785 USD
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.018 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.036 pure
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
134986 USD
CY2018 gblx Income Tax Reconciliation Prior Year Tax Penalties
IncomeTaxReconciliationPriorYearTaxPenalties
53955 USD
CY2018 gblx Income Tax Reconciliation Accrued Interest On Prior Year Tax Liabilities
IncomeTaxReconciliationAccruedInterestOnPriorYearTaxLiabilities
22754 USD
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
506145 USD
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
178727 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
896495 USD
CY2021 gblx Income Tax Reconciliation Prior Year Tax Penalties
IncomeTaxReconciliationPriorYearTaxPenalties
207945 USD
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
168527 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
592982 USD
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
51507562 USD
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
51063886 USD
CY2022Q1 gblx Operating Loss Carryforwards Subject To Expiration
OperatingLossCarryforwardsSubjectToExpiration
34481122 USD
CY2022Q1 gblx Operating Loss Carryforwards Not Subject To Expiration
OperatingLossCarryforwardsNotSubjectToExpiration
17026440 USD
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
691042 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-697040 USD
CY2022 gblx Effective Income Tax Rate Reconciliation Irc Section280e Amount
EffectiveIncomeTaxRateReconciliationIrcSection280eAmount
132063 USD
CY2021 gblx Effective Income Tax Rate Reconciliation Irc Section280e Amount
EffectiveIncomeTaxRateReconciliationIrcSection280eAmount
173045 USD
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
5526 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
14407 USD
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
579861 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
26720 USD
CY2022 gblx Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets
EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets
-1408492 USD
CY2021 gblx Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets
EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets
603319 USD
CY2022 gblx Effective Income Tax Rate Reconciliation Tax Return Trueup
EffectiveIncomeTaxRateReconciliationTaxReturnTrueup
58277 USD
CY2021 gblx Effective Income Tax Rate Reconciliation Tax Return Trueup
EffectiveIncomeTaxRateReconciliationTaxReturnTrueup
0 USD
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58277 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
120451 USD
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
76709 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
48076 USD
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
134986 USD
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
168527 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3144084 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3131344 USD
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10816588 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10460788 USD
CY2022Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
975461 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1369 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
458938 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
209714 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
220795 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13749589 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14329450 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13749589 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14329450 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
84538161
CY2021 gblx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
43493809
CY2021 gblx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.10
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
85843036
CY2022 gblx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
2095333
CY2022 gblx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.10
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75124673
CY2022 gblx Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
60667 USD
CY2021 gblx Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
211000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17333 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
CY2021Q4 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 USD
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 USD
CY2021Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
513901 USD

Files In Submission

Name View Source Status
0001437749-22-016285-index-headers.html Edgar Link pending
0001437749-22-016285-index.html Edgar Link pending
0001437749-22-016285.txt Edgar Link pending
0001437749-22-016285-xbrl.zip Edgar Link pending
ex_357716.htm Edgar Link pending
ex_357733.htm Edgar Link pending
ex_357734.htm Edgar Link pending
ex_357735.htm Edgar Link pending
ex_357736.htm Edgar Link pending
ex_357737.htm Edgar Link pending
ex_388869.htm Edgar Link pending
ex_388877.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gblx-20220331.xsd Edgar Link pending
gblx-20220331_cal.xml Edgar Link unprocessable
gblx-20220331_def.xml Edgar Link unprocessable
gblx-20220331_lab.xml Edgar Link unprocessable
gblx-20220331_pre.xml Edgar Link unprocessable
gblx20220331b_10k.htm Edgar Link pending
gblx20220331b_10k_htm.xml Edgar Link completed
logo1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending